Management of post-transplant lymphoproliferative disorders

被引：1
|
作者：
Dierickx, Daan [1 ]
Vergote, Vibeke [1 ]
机构：
[1] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium
来源：
HEMASPHERE | 2019年 / 3卷
关键词：
RECIPIENTS; INFUSIONS; PROGNOSIS;
D O I：
10.1097/HS9.0000000000000226
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Take home messages Reduction of immune suppression followed by rituximab has become the standard of care in the majority of post-transplant lymphoproliferative disorders. Currently pre-emptive therapy is only justified in allogeneic hematopoietic stem cell recipients. Adoptive immunotherapy is a very promising therapeutic modality, both in pre-emptive setting and as treatment of established Epstein-Barr virus-positive post-transplant lymphoproliferative disorder. However, use is still restricted because of labor-intensive procedure, reimbursement issues, and availability problems.
引用
收藏
页码：74 / 77
页数：4
相关论文
共 50 条
  • [41] Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders
    Borenstein, J.
    Pezzella, F.
    Gatter, K. C.
    HISTOPATHOLOGY, 2007, 51 (06) : 774 - 777
  • [42] Comparative genomic hybridization in monomorphous post-transplant lymphoproliferative disorders
    Nelson, M
    Neppalli, V
    VanDyke, Z
    Dave, B
    Coad, J
    Sanger, W
    Greiner, TC
    MODERN PATHOLOGY, 2005, 18 : 243A - 243A
  • [43] POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS 2nd EDITION
    Engels, Eric A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 (04) : 1271 - 1271
  • [44] Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)
    Nalesnik, MA
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1998, 20 (3-4): : 325 - 342
  • [45] Post-transplant lymphoproliferative disease
    Dharnidharka, Vikas R.
    Araya, Carlos E.
    PEDIATRIC NEPHROLOGY, 2009, 24 (04) : 731 - 736
  • [46] Interferon-α and its effects on post-transplant lymphoproliferative disorders
    Albert Faro
    Springer Seminars in Immunopathology, 1998, 20 : 425 - 436
  • [47] Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)
    Michael A. Nalesnik
    Springer Seminars in Immunopathology, 1998, 20 : 325 - 342
  • [48] CD30 Expression in Post-Transplant Lymphoproliferative Disorders
    Hartley, Christopher
    Hintzke, Maria
    Vaughan, James
    Hosking, Paul
    Harrington, Alexandra
    Kroft, Steven
    Olteanu, Horatiu
    MODERN PATHOLOGY, 2015, 28 : 349A - 349A
  • [49] DA-EPOCH-R for post-transplant lymphoproliferative disorders
    DeStefano, Christin B.
    Malkovska, Vera
    Rafei, Hind
    Shenoy, Aarthi
    Fitzpatrick, Kelly
    Aggarwal, Anita
    Catlett, Joseph P.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (03) : 283 - 285
  • [50] Comparative genomic hybridization in monomorphous post-transplant lymphoproliferative disorders
    Nelson, M
    Neppalli, V
    Van Dyke, Z
    Dave, B
    Coad, J
    Sanger, W
    Greiner, TC
    LABORATORY INVESTIGATION, 2005, 85 : 243A - 243A
12345